Mount Yale Investment Advisors LLC Has $300,000 Stake in Colgate-Palmolive (NYSE:CL)

Mount Yale Investment Advisors LLC grew its holdings in Colgate-Palmolive (NYSE:CL) by 5.5% during the 4th quarter, HoldingsChannel reports. The firm owned 3,299 shares of the company’s stock after acquiring an additional 173 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Colgate-Palmolive were worth $300,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. D Orazio & Associates Inc. boosted its holdings in Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the last quarter. Fiducient Advisors LLC raised its position in shares of Colgate-Palmolive by 5.2% in the 3rd quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after acquiring an additional 110 shares during the period. Sequoia Financial Advisors LLC boosted its stake in Colgate-Palmolive by 0.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after acquiring an additional 113 shares during the last quarter. Great Waters Wealth Management grew its holdings in Colgate-Palmolive by 1.5% during the third quarter. Great Waters Wealth Management now owns 7,669 shares of the company’s stock valued at $796,000 after purchasing an additional 117 shares during the period. Finally, Waldron Private Wealth LLC increased its stake in Colgate-Palmolive by 2.1% in the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock valued at $585,000 after purchasing an additional 118 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Trading Down 0.2 %

NYSE CL opened at $89.65 on Thursday. The company has a market cap of $73.24 billion, a PE ratio of 25.69, a PEG ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The stock has a 50 day moving average of $91.67 and a 200-day moving average of $97.34. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.23%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Activity

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CL has been the subject of several research analyst reports. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday, January 17th. Stifel Nicolaus cut their price objective on Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. TD Cowen lowered their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Finally, UBS Group dropped their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $102.00.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.